The World Market for Cancer Diagnostics, 2021

Kalorama Information’s The World Market for Cancer Diagnostics, 2021 offers an in-depth and authoritative analysis of the rapidly evolving cancer testing industry. This comprehensive report provides market sizing, opportunity assessments, and insights into industry mergers and trends, essential for stakeholders and decision-makers in the healthcare sector.

 

Market Segments:

Explore detailed market data across key IVD segments used in cancer diagnostics, including:

• Immunoassay – Tumor Markers: Analysis of tumor marker assays used for cancer diagnosis.
• Molecular – Cancer Assays: In-depth look at molecular diagnostics for cancer.
• Molecular – Histology: Insights into histological tests for cancer.
• Molecular – HPV: Market analysis of HPV testing in cancer diagnostics.
• CTCs: Evaluation of circulating tumor cell (CTC) assays.

 

Industry Trends and Innovations:

The critical need for innovative diagnostic tools is driven by the high prevalence of cancer in developed regions. This report covers:

• New Imaging Tools: Emerging technologies enhancing cancer detection.
• Bioinformatics and Sequencing Technologies: Advanced tools revolutionizing cancer diagnostics.
• Improved Histological Tests: Enhancements in traditional histological testing methods.
• Investments and Financing Agreements: Analysis of recent investments and financing in the cancer diagnostics field.
• Partnerships and Acquisitions: Overview of key partnerships and acquisitions involving cancer diagnostic companies.

Market Analysis:

Understand the global landscape of cancer diagnostics with a focus on:

• World Markets for In Vitro Cancer Diagnostics: Comprehensive market analysis with a bias towards developed regions like North America, Japan, and Western Europe.
• Industrialized Developing Countries: Insights into cancer testing markets in Latin America and Asia Pacific.

Personalized and Precision Medicine:

The report delves into the evolution from personalized to precision medicine, highlighting the growing market for:

• Pharmacogenomic and Pharmacogenetic Tests: Fast-growing segments of the cancer diagnostics market.
• Companion Tests: Integration of companion diagnostics in clinical practice.
• Automation in Sample Preparation and Assays: Advancements in instrumentation reducing labor intensity.
• Government and Private Payer Reimbursements: Increasing acceptance and coverage for new molecular tools.

 

Competitor Analysis:

Gain unparalleled insights into top-tier IVD companies and specialized cancer diagnostics firms. This section includes:

• Diagnostic Modalities for Solid Tumors: Focus on in vitro tests for solid tumors.
• Role of In Vitro and In Vivo Tests: Discussion on the interconnected roles of in vitro and in vivo diagnostics in cancer management.

Detailed Company Profiles:

The report provides extensive reviews of current products and those in development, along with detailed profiles of leading companies in the cancer diagnostics space.

 

Table: Cancer IVD Market Revenues, 2021-2026 ($ millions)

Segment	2021	2022	2023	2024	2025	2026	CAGR
Immunoassay – IHC	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
Immunoassay – tumor markers	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
Molecular – histology (ISH)	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
Molecular – cancer assays	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
Molecular – HPV	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
CTCs	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
Total	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%

Source: Kalorama Information

For further details and to purchase directly, please contact us.